Developing Implementation Strategies to Improve Access to Transitional Opioid Programs in Safety Net Hospitals
制定实施策略以改善安全网医院过渡性阿片类药物计划的可及性
基本信息
- 批准号:10671082
- 负责人:
- 金额:$ 23.46万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-08-01 至 2025-06-30
- 项目状态:未结题
- 来源:
- 关键词:AcuteAddressAdoptedAdoptionBudgetsBuprenorphineCaringCatalogsCenters for Disease Control and Prevention (U.S.)CharacteristicsChronicCollaborationsCommunicable DiseasesCommunitiesCommunity HospitalsDataDecision MakingDisparityEconomic BurdenEconomicsEndocarditisEnsureEvidence based programExtramural ActivitiesFaceFundingFutureGoalsHIV/HCVHarm ReductionHealthHealth ServicesHealth Services AccessibilityHealthcare SystemsHospitalizationHospitalsImprove AccessInstitutionInterdisciplinary Health TeamInterventionInterviewInvestmentsKnowledgeLinkLogistic RegressionsMedicaidMethodsMorbidity - disease rateOpioidOutcomeOutpatientsOverdosePatientsPatternPersonsPlayProviderPublic HealthPublicationsRandomized, Controlled TrialsReportingResearchResearch PersonnelResourcesRoleSamplingScheduleService provisionServicesSiteSkin TissueSoft Tissue InfectionsStressTestingTimeTypologyUnderinsuredUninsuredUnited Statesaddictionbeneficiarycommunity barriercommunity based servicecommunity partnershipdisease transmissioneffectiveness testingevidence basefollow-upimplementation barriersimplementation scienceimplementation strategyimprovedlongitudinal databasemedication for opioid use disordermortalityopioid misuseopioid overdoseopioid useopioid use disorderpatient engagementprogramsrural settingsafety netsecondary infectionsocialsocial stigmatrendunderserved communityuptakeurban setting
项目摘要
Project Summary/Abstract:
Opioid use disorder (OUD) is a pressing public health problem nationwide but is increasing rapidly in
underserved communities where there is currently a shortage of services, particularly evidence-based
transitional opioid programs (TOPs) which link patients in hospitals to harm reduction and treatment resources.
Hospitals are ideal sites to address OUD and engage patients given the relationship between opioid use and
misuse and a number of acute health conditions, including overdose and infectious disease. Evidence
suggests that hospitals are highly motivated to participate in offering new interventions due to the economic
and social toll of untreated OUD. Safety net hospitals, however, face considerable barriers to adopting TOPs
and have been significantly less likely to offer OUD services in their communities. To engage safety-net
hospitals effectively and help them implement opioid programs such as TOPs, more information is needed on
implementation barriers to tailor implementation strategies that will be most effective given the local constraints
faced by safety-net providers.
Using a combination of the latest publicly available community benefits reports and Internal Revenue
Service Schedule H data, we will catalog hospitals’ OUD services, including TOPs, and assess the relationship
between the adoption of TOP and various community and hospital characteristics, including safety-net status,
and examine trends in the availability of OUD services across time (Aim 1). We will then interview hospital
decision makers and community partners at five diverse safety net hospitals to better understand barriers and
facilitators to adopting and implementing TOPs. (Aim 2). Finally, we will convene an expert panel to identify
high-yield and tailored implementation strategies to increase the availability of transitional opioid programs and
other evidence-based opioid services in underserved communities (Aim 3). As an interdisciplinary team of
health services researchers, we have a strong record of collaborative publication and extramural funding
related to hospital-community partnerships and opioid services. The implementation strategies developed in
this study will lead to a future cluster randomized controlled trial to test the effectiveness of tailoring
implementation strategies to safety net settings. The long term outcome is to increase the availability of TOPs
in communities where significant disparities currently exist.
项目摘要/摘要:
阿片类药物使用障碍 (OUD) 是全国范围内一个紧迫的公共卫生问题,但在
服务不足的社区,目前缺乏服务,特别是基于证据的服务
过渡性阿片类药物计划 (TOP) 将医院患者与减少伤害和治疗资源联系起来。
考虑到阿片类药物使用与患者之间的关系,医院是解决 OUD 问题并吸引患者参与的理想场所。
滥用和一些急性健康问题,包括用药过量和传染病。证据
表明由于经济的原因,医院非常积极地参与提供新的干预措施
以及未经处理的 OUD 造成的社会损失。然而,安全网医院在采用 TOP 方面面临相当大的障碍
并且在其社区提供 OUD 服务的可能性明显较小。建立安全网
医院有效地帮助他们实施阿片类药物计划,例如 TOP,需要更多信息
实施障碍 考虑到当地的限制,制定最有效的实施战略
安全网提供商面临的问题。
结合使用最新公开的社区福利报告和国内收入
Service Schedule H数据,我们将对医院的OUD服务进行分类,包括TOP,并评估关系
TOP 的采用与各种社区和医院特征(包括安全网状况)之间的关系,
并检查 OUD 服务可用性随时间变化的趋势(目标 1)。然后我们会采访医院
五家不同安全网医院的决策者和社区合作伙伴更好地了解障碍和
采用和实施 TOP 的促进者。 (目标 2)。最后,我们将召集专家小组来确定
高收益和量身定制的实施战略,以增加过渡性阿片类药物计划的可用性
在服务不足的社区提供其他循证阿片类药物服务(目标 3)。作为一支跨学科团队
卫生服务研究人员,我们在合作出版和外部资助方面拥有良好的记录
与医院-社区伙伴关系和阿片类药物服务有关。制定的实施策略
这项研究将导致未来进行整群随机对照试验,以测试定制的有效性
安全网设置的实施策略。长期结果是增加 TOP 的可用性
在目前存在显着差异的社区中。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ji E Chang其他文献
Barriers and Facilitators to Establishing Partnerships for Substance Use Disorder Care Transitions Between Safety-Net Hospitals and Community-Based Organizations.
在安全网医院和社区组织之间建立药物使用障碍护理过渡伙伴关系的障碍和促进因素。
- DOI:
- 发表时间:
2024 - 期刊:
- 影响因子:5.7
- 作者:
Zoe Lindenfeld;Berkeley Franz;A. Lai;José A Pagán;Cheyenne Fenstemaker;Cory E. Cronin;Ji E Chang - 通讯作者:
Ji E Chang
Trends in the Prioritization and Implementation of Substance Use Programs by Nonprofit Hospitals: 2015–2021
非营利性医院药物使用计划的优先顺序和实施趋势:2015-2021
- DOI:
10.1097/adm.0000000000001128 - 发表时间:
2022 - 期刊:
- 影响因子:5.5
- 作者:
Ji E Chang;Cory E. Cronin;J. Pagán;Janet E Simon;Zoe Lindenfeld;Berkeley Franz - 通讯作者:
Berkeley Franz
Hospital adoption of harm reduction and risk education strategies to address substance use disorders
医院采用减少伤害和风险教育策略来解决药物使用障碍
- DOI:
10.1080/00952990.2023.2169832 - 发表时间:
2023 - 期刊:
- 影响因子:0
- 作者:
Zoe Lindenfeld;Berkeley Franz;Cory E. Cronin;Ji E Chang - 通讯作者:
Ji E Chang
Ji E Chang的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ji E Chang', 18)}}的其他基金
Developing Implementation Strategies to Improve Access to Transitional Opioid Programs in Safety Net Hospitals
制定实施策略以改善安全网医院过渡性阿片类药物计划的可及性
- 批准号:
10526578 - 财政年份:2022
- 资助金额:
$ 23.46万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 23.46万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 23.46万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 23.46万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 23.46万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 23.46万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 23.46万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 23.46万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 23.46万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 23.46万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 23.46万 - 项目类别:
Research Grant














{{item.name}}会员




